Anticancer activity and anti-inflammatory studies of 5-aryl-1,4-benzodiazepine derivatives

Anticancer Agents Med Chem. 2012 Jul;12(6):611-8. doi: 10.2174/187152012800617713.

Abstract

A series of 5-aryl-1,4-benzodiazepines with chloro- or fluoro-substituents in the second ring have been synthesized and their anti-inflammatory, myeloperoxidase and anticancer properties studied. The synthesized compounds showed potential anti-inflammatory and anticancer activities, which were enhanced in the presence of a chloro-substituent in the second ring of the 5-aryl-1,4- benzodiazepine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemical synthesis*
  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Benzodiazepines / chemical synthesis*
  • Benzodiazepines / pharmacology
  • Cell Line, Tumor
  • Crystallography, X-Ray
  • Dose-Response Relationship, Drug
  • Edema / drug therapy
  • Female
  • Halogenation
  • Humans
  • Inflammation / drug therapy
  • Inhibitory Concentration 50
  • Male
  • Mice
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Peroxidase / antagonists & inhibitors*
  • Peroxidase / metabolism
  • Structure-Activity Relationship

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Benzodiazepines
  • Peroxidase